Rocket Lab USA, Inc. (NASDAQ:RKLB) (“Rocket Lab” or “the Company”), a leading launch and space systems company, today confirmed it has completed a final launch rehearsal and is ready for lift-off for its first mission from U.S. soil as early as December 7. The mission will take place from Rocket Lab Launch Complex 2 at Virginia Space’s Mid-Atlantic Regional Spaceport within NASA’s Wallops Flight Facility – a launch pad developed to support U.S. Electron missions for government and commercial customers.
Leap Therapeutics To Present New Data From Part A Of The DeFianCe Study Of DKN-01 Plus Bevacizumab And Chemotherapy In Colorectal Cancer Patients At The 2024 ASCO Gastrointestinal Cancers Symposium
Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that the Company will be presenting new data in second-line patients
